Mengyong Yan
Executive Director
About
My great passion is translational research especially cancer therapy. My major focus is always on immunotherapy. My past tweenty years research focus on dendritic cell antigen presentation of HPV VLPs, Cytotoxic T cell generation against tumor antigen, T cell receptor cloning, T cell receptor (TCR-T) and Chimeraic antigen receptor (CAR-T) gene transfer in T cell, and Gamma delta T cells features and fucnctions and its application in immunotherapy against cancer.
China
Jiangsu
Biotechnology
Quality Control, Biotechnology, Cell Therapy, Translational Medicine, Cancer Research, Oncology Clinical Research, Project Team Management, Bioscience, Interpersonal Skills, IO, Senior Administration, Director level, Assay Development, Immunotherapy, Cancer, Clinical Research, Cancer Immunotherapy, Immunology, Mammalian Cell Culture, T cells
Experience

Executive Director
Tioc Therapeutic LTD
Shanghai, China
Biulding-up and Establishing CMC (PD, GMP and QC) for TCR redirect cellular immunotherapy

Senior Director
Suzhou, Jiangsu, China
General management of R&D, PD (Process Development), GMP grade manufacturing of universal cellular therapy products including CAR-T (uCAR-T) against various cancer. Establishing PD, GMP manufacturing of universal CAR-T (uCAR-T) for clinical trial. Establishing the biomarker monitoring programme for the uCAR-T clinical trial.

Principal Scientist
Guangzhou, Guangdong, China
Responsible for producing tumour specific TCR gene transduced T cell (TCR-T) with aim for clinical trial. Lead a team to develop pre-clinical research about the tumour specific high avidity TCR transduced T cell against cancer. Lead a team to optimasition the protocols for the manufacturing of GMP grade TCR transduced T cell Responsible for the manufacturing TCR transduced T cell for the ongoing clinical trial. Developed various bioassays including functional and phenotypical assays for the monitoring of clinical trials with the aim to identify clinical biomarkers for patient selection, efficacy prediction and monitoring.

Postdoctoral Research Fellow
Institute of Child Health, UCL
London, United Kingdom
Generate tumor specific CTL TCR cDNA library from transgenic mice. De-methylation effects for tumor antigenicity and improve effects for CTL killing. Stat 3 inhibition effects on CTL survival and killing.

Specialist in Gastroenterology
Chengdu General Hopital
Chengdu, Sichuan, China
Clinical practice specialised in Gastroenterology
Education
Mengyong Yan's Contact Information
Phone
Find the Right Leads
Find Verified Contact Data
What LeadContact does well
Find verified emails, phone numbers, and decision-makers with 98% accuracy.
Find Leads
Find the right people by company, role, industry, location, and more.
925M+ professional profiles

Find Emails
Access verified email addresses for your target contacts.
657M+ emails

Find Phone Numbers
Get cross-validated phone data from multiple top sources.
239M+ phone numbers

More Accurate. Lower Cost.
Find contact data in 1 tool with 98% accuracy
LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.
Great conversations start with the right contact.
It’s time to find yours.





